Results 41 to 50 of about 91,065 (316)
Pharmaceuticals, 2022 Despite increasing reports, antidepressant (AD) misuse and dependence remain underestimated issues, possibly due to limited epidemiological and pharmacovigilance evidence.
Stefania Chiappini +5 more
doaj +1 more source
Self-medication with Novel Psychoactive Substances (NPS): a Systematic Review
International Journal of Mental Health and Addiction, 2023 Currently, novel psychoactive substance (NPS) use presents a challenging issue for authorities. To effectively tackle the use of NPS, a deeper understanding of the motivations of those who use NPS is required. Evidence suggests that a subset of NPS users
Tayler Holborn +3 more
semanticscholar +1 more source
Novel psychoactive substances: a novel clinical challenge [PDF]
BMJ Case Reports, 2013 The recreational use of novel psychoactive substances in the UK has increased markedly within the last decade. The variety of new substances synthesised and sold as ‘legal’, often under the pretence of being ‘plant food’ or ‘bath salts’ is similarly increasing. This presents challenges to clinicians: they may be unaware of these substances or unable to
Christopher Daniel, Smith +2 more
openaire +2 more sources
Stimulant and hallucinogenic novel psychoactive substances; an update
Expert Review of Clinical Pharmacology, 2023 Introduction The renewed interest in considering a range of stimulants, psychedelics and dissociatives as therapeutics emphasizes the need to draft an updated overview of these drugs’ clinical and pharmacological issues.
F. Schifano +3 more
semanticscholar +1 more source
What about “Pharming”? Issues Regarding the Misuse of Prescription and Over-the-Counter Drugs
Brain Sciences, 2020 Recently, a range of prescription and over-the-counter (OTC) drugs have emerged as being used recreationally, either on their own or in combination with other substances, both licit and illicit, including new psychoactive substances (NPS).
Stefania Chiappini, Fabrizio Schifano
doaj +1 more source
SODAS: Surveillance of Drugs of Abuse Study [PDF]
, 2017 Objective: Novel Psychoactive Substance (NPS) as a form of recreational drug use has become increasingly popular. There is a paucity of information with regards the prevalence and clinical sequalae of these drugs.
Bloeck, Felix +4 more
core +1 more source
Talanta: The International Journal of Pure and Applied Analytical Chemistry, 2023 In this paper, the development of efficient enantioselective HPLC methods for the analysis of five benzofuran-substituted phenethylamines, two substituted tryptamines, and three substituted cathinones is described.
M. Protti +8 more
semanticscholar +1 more source
Synthetic cannabinoid use in a case series of patients with psychosis presenting to acute psychiatric settings : Clinical presentation and management issues [PDF]
, 2018 Background: Novel Psychoactive Substances (NPS) are a heterogeneous class of synthetic molecules including synthetic cannabinoid receptor agonists (SCRAs). Psychosis is associated with SCRAs use.
Bonaccorso, Stefania +9 more
core +3 more sources
Clinical toxicology, 2022 Introduction Novel psychoactive substances (NPS) have been increasingly reported in the last 15–20 years. We aimed to describe presentations to the emergency department (ED) with acute recreational drug toxicity involving NPS. Methods Data were extracted
B. Crulli +12 more
semanticscholar +1 more source
Detecting a signal in the noise : Monitoring the global spread of novel psychoactive substances using media and other open source information [PDF]
, 2015 This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no ...
Canadian Community Epidemiology Network On Drug Use +3 more
core +1 more source